Strongyloides stercoralis colitis in a patient positive for human T-cell leukaemia virus with rheumatoid arthritis during an anti-rheumatic therapy: a case report

References

• Schär F, Trostdorf U, Giardina F, et al. Strongyloides stercoralis: global distribution and risk factors. PLoS Negl Trop Dis. 2013;7(7):e2288.
   PubMed Web of Science ®Google Scholar
• Schierhout G, McGregor S, Gessain A, et al. Association between HTLV-1 infection and adverse health outcomes: a systematic review and meta-analysis of epidemiological studies. Lancet Infect Dis. 2020;20(1):133–143.
   PubMed Web of Science ®Google Scholar
• Carvalho EM, Da Fonseca Porto A. Epidemiological and clinical interaction between HTLV-1 and Strongyloides stercoralis. Parasite Immunol. 2004;26(11-12):487–497.
   PubMed Web of Science ®Google Scholar
• Hirata T, Uchima N, Kishimoto K, et al. Impairment of host immune response against Strongyloides stercoralis by human T cell lymphotropic virus type 1 infection. Am J Trop Med Hyg. 2006;74(2):246–249.
   PubMed Web of Science ®Google Scholar
• Ashiri A, Beiromvand M, Khanzadeh A. Strongyloides stercoralis infection in a patient with rheumatoid arthritis and type 2 diabetes mellitus: a case-based review. Clin Rheumatol. 2019;38(11):3093–3098.
   Web of Science ®Google Scholar
• Altintop L, Cakar B, Hokelek M, et al. Strongyloides stercoralis hyperinfection in a patient with rheumatoid arthritis and bronchial asthma: a case report. Ann Clin Microbiol Antimicrob. 2010;9:27.
   PubMed Web of Science ®Google Scholar
• Krishnamurthy R, Dincer HE, Whittemore D. Strongyloides stercoralis hyperinfection in a patient with rheumatoid arthritis after anti-TNF-alpha therapy. J Clin Rheumatol. 2007;13:150–152.
   Web of Science ®Google Scholar
• Boatright MD, Wang BW. Clinical infection with Strongyloides sterocoralis following etanercept use for rheumatoid arthritis. Arthritis Rheum. 2005;52(4):1336–1337.
   Google Scholar
• Vasquez-Rios G, Pineda-Reyes R, Pineda-Reyes J, et al. Strongyloides stercoralis hyperinfection syndrome: a deeper understanding of a neglected disease. J Parasit Dis. 2019;43(2):167–175.
   PubMedGoogle Scholar
• Geri G, Rabbat A, Mayaux J, et al. Strongyloides stercoralis hyperinfection syndrome: a case series and a review of the literature. Infection. 2015;43(6):691–698.
   Web of Science ®Google Scholar
• Qu Z, Kundu UR, Abadeer RA, et al. Strongyloides colitis is a lethal mimic of ulcerative colitis: the key morphologic differential diagnosis. Hum Pathol. 2009;40(4):572–577.
   Web of Science ®Google Scholar
• Poveda J, El-Sharkawy F, Arosemena LR, et al. Strongyloides colitis as a harmful mimicker of inflammatory bowel disease. Case Rep Pathol. 2017;2017:2560719.
   Web of Science ®Google Scholar
• Hayashi J, Kishihara Y, Yoshimura E, et al. Correlation between human T cell lymphotropic virus type-1 and Strongyloides stercoralis infections and serum immunoglobulin E responses in residents of Okinawa. Japan. Am J Trop Med Hyg. 1997;56(1):71–75.
   Web of Science ®Google Scholar
• Iwanaga M, Watanabe T, Utsunomiya A, et al.; for the Joint Study on Predisposing Factors of ATL Development investigators. Joint study on predisposing factors of ATL development investigators. Human T-cell leukemia virus type I (HTLV-1) proviral load and disease progression in asymptomatic HTLV-1 carriers: a nationwide prospective study in Japan. Blood. 2010;116(8):1211–1219.
   PubMed Web of Science ®Google Scholar
• Vasquez-Rios G, Pineda-Reyes R, Ruiz EF, et al. Strongyloides stercoralis infection after the use of emergency corticosteroids: a case report on hyperinfection syndrome. J Med Case Rep. 2019;13:121–128.
   PubMedGoogle Scholar
• Adachi Y, Hinoda Y, Takahashi H, et al. Rheumatoid arthritis associated with ulcerative colitis. J Gastroenterol. 1996;31(4):590–595.
   Web of Science ®Google Scholar
• Sugisaki K, Honma F, Iwadate H, et al. Ulcerative colitis occurring in the course of rheumatoid arthritis: a case successfully treated with mesalamine enema. Intern Med. 2004;43(11):1046–1050.
   Web of Science ®Google Scholar
• Asada Y, Isomoto H, Shikuwa S, et al. Development of ulcerative colitis during the course of rheumatoid arthritis: association with selective IgA deficiency. World J Gastroenterol. 2006;12(32):5240–5243.
   Web of Science ®Google Scholar
• Motohashi R, Ikeuchi H, Hiromura K, et al. Two cases of ulcerative colitis developing in rheumatoid arthritis patients during abatacept therapy. Scand J Gastroenterol. 2014;49(10):1270–1271.
   PubMed Web of Science ®Google Scholar
• Gutierrez Y, Bhatia P, Garbadawala ST, et al. Strongyloides stercoralis eosinophilic granulomatous enterocolitis. Am J Surg Pathol. 1996;20(5):603–612.
   Web of Science ®Google Scholar
• Lemos LB, Qu Z, Laucirica R, et al. Hyperinfection syndrome in strongyloidiasis: report of two cases. Ann Diagn Pathol. 2003;7(2):87–94.
   Google Scholar
• Carp NZ, Nejman JH, Kelly JJ. Strongyloidiasis. An unusual cause of colonic pseudopolyposis and gastrointestinal bleeding. Surg Endosc. 1987;1(3):175–177.
   Google Scholar
• Stoopack PM, Raufman JP. Aphthoid ulceration of the colon in strongyloidiasis. Am J Gastroenterol. 1991;86:639–642.
   Web of Science ®Google Scholar
• Linder JD, Mönkemüller KE, Lazenby AJ, et al. Streptococcus bovis bacteremia associated with Strongyloides stercoralis colitis. Gastrointest Endosc. 2000;52(6):796–798.
   Web of Science ®Google Scholar
• Click B, Anderson AM, Koutroubakis IE, et al. Peripheral eosinophilia in patients with inflammatory bowel disease defines an aggressive disease phenotype. Am J Gastroenterol. 2017;112:1849–1858.
   PubMed Web of Science ®Google Scholar
• Robinson RD, Lindo JF, Neva FA, et al. Immunoepidemiologic studies of Strongyloides stercoralis and human T lymphotropic virus type I infections in Jamaica. J Infect Dis. 1994;169(3):692–696.
   Web of Science ®Google Scholar
• Marsh BJ. Infectious complications of human T cell leukemia/lymphoma virus type I infection. Clin Infect Dis. 1996;23(1):138–145.
   PubMed Web of Science ®Google Scholar
• Gotuzzo E, Terashima A, Alvarez H, et al. Strongyloides stercoralis hyperinfection associated with human T cell lymphotropic virus type-1 infection in Peru. Am J Trop Med Hyg. 1999;60(1):146–149.
   PubMed Web of Science ®Google Scholar
• Montes M, Sanchez C, Verdonck K, et al. Regulatory T cell expansion in HTLV-1 and strongyloidiasis co-infection is associated with reduced IL-5 responses to Strongyloides stercoralis antigen. PLoS Negl Trop Dis. 2009;3(6):e456.
   PubMed Web of Science ®Google Scholar
• Gillet NA, Cook L, Laydon DJ, et al. Strongyloidiasis and infective dermatitis alter human T lymphotropic virus-1 clonality in vivo. PLoS Pathog. 2013;9(4):e1003263.
   PubMed Web of Science ®Google Scholar
• Neva FA, Filho JO, Gam AA, et al. Interferon-gamma and interleukin-4 responses in relation to serum IgE levels in persons infected with human T lymphotropic virus type I and Strongyloides stercoralis. J Infect Dis. 1998;178(6):1856–1859.
   Web of Science ®Google Scholar
• Porto AF, Neva FA, Bittencourt H, et al. HTLV-1 decreases Th2 type of immune response in patients with strongyloidiasis. Parasite Immunol. 2001;23(9):503–507.
   Web of Science ®Google Scholar
• Marcos LA, Terashima A, Canales M, et al. Update on strongyloidiasis in the immunocompromised host. Curr Infect Dis Rep. 2011;13(1):35–46.
   Google Scholar
• Umekita K, Hashiba Y, Iwao K, et al. Human T-cell leukemia virus type 1 may invalidate T-SPOT.TB assay results in rheumatoid arthritis patients: A retrospective case-control observational study. PLoS One. 2020;15(5):e0233159.
   Web of Science ®Google Scholar
• Satoh M, Kiyuna S, Shiroma Y, et al. Predictive markers for development of strongyloidiasis in patients infected with both Strongyloides stercoralis and HTLV-1. Clin Exp Immunol. 2003;133(3):391–396.
   Web of Science ®Google Scholar